Globe Newswire
Nearly 30 delegates will participate in the New Mexico Pavilion to create new connections and drive interest in the state’s bioscience industry
Albuquerque, NM, June 03, 2024 (GLOBE NEWSWIRE) -- A delegation of government, economic development, association and industry leaders and businesses will represent the New Mexico bioscience industry at the BIO International Convention in San Diego June 3-6. The Albuquerque Regional Economic Alliance (AREA) will promote the... (continue reading...)
FRAMINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today released its 2023 sustainability report. The second annual report showcases Definitive Healthcare’s ongoing commitment to operating ethically, responsibly, and sustainably through the implementation and management of environmental, social, and governance (ESG) practices.
“We are firm believers in achieving our... (continue reading...)
Announcement on the Nasdaq Tower in New York City can be viewed at https://youtu.be/28nV8L_TXaw?si=Fb1_EBN7LQcLGfFb
Livestreams of the Expo’s conferences will be available on RaiNews.it and Today.it
Rome, Italy – June 3, 2024: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT)... (continue reading...)
SASKATOON, Saskatchewan, June 03, 2024 (GLOBE NEWSWIRE) -- Royal University Hospital Foundation and BHP are pleased to announce a $1 million donation from BHP that will transform the way the most utilized diagnostic procedure – X-ray imaging -- is done at Royal University Hospital (RUH).
BHP’s donation to Royal University Hospital Foundation to fund new state-of-the-art digital technology for RUH’s two busiest X-ray suites will replace outdated computer and... (continue reading...)
HOUSTON, June 03, 2024 (GLOBE NEWSWIRE) -- 7 Hills Pharma Inc. (“7 Hills” or “7HP”), a clinical-stage pharma company leveraging a novel mechanism of action to safely enhance the effectiveness of cancer immunotherapies, was awarded $4.7 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to support its cell/gene therapy (CGT) development program. This grant will allow 7 Hills to advance 7HP935, the Company’s lead first-in-class small... (continue reading...)
More Globe Newswire
View Older Stories-
InspireSemi Announces Delayed 2023 Annual General and Special Meeting as Well as Periodic Business Update Date and Time
-
L’Oréal announces launch of fourth employee share ownership plan
-
PRESS RELEASE: BIGBEN: 2023/24: STRONG EARNINGS GROWTH
-
Transaction in Own Shares
-
Oswego Health Partners with Wellthy to Deliver Comprehensive Caregiving Support to Employees and their Families
-
PracticeLink Unveils New Enhanced Website to Serve Physician and Recruiter Communities
-
Voltalia passes three gigawatts of capacity thanks to new Helexia solar roofs in Portugal
-
Declaration of number of voting rights
-
Toll Brothers at Willow Community Now Open in Punta Gorda, Florida
-
Toll Brothers Now Offering Move-In Ready Homes at Park 108 in Decatur, Georgia
-
CN Partners with Canada’s Sports Hall of Fame in Support of Indigenous Athletes and their Stories
-
UNFCCC Partners with Qlik to Drive Data-Driven Climate Action
-
Disclosure of trading in own shares from May 27th to May 31st, 2024
-
PRESS RELEASE: NACON: STRONG EARNINGS GROWTH IN 2023/24
-
Significant Results From Diamond Drilling at Belltopper, Victoria
-
Significant Results From Diamond Drilling at Belltopper, Victoria
-
Optimove to Highlight Data Extensions, its Latest Advancement to its Customer-Led Marketing Platform, at the 2024 Gartner® Marketing Symposium| Xpo™ in Denver, June 3-5
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Checkpoint
-
Kirby McInerney LLP Reminds Lincoln National Corporation (LNC) Investors of Class Action Filing and Encourages Investors to Contact the Firm
-
Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascular emergencies
-
BGHL (GBP): Estimated NAV(s)
-
BGHL (EUR): Estimated NAV(s)
-
American Humane Kicks Off 14th Annual Hero Dog Awards
-
Blank Rome Welcomes Leading Maritime Partner Luke Reid in Boston
-
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
-
WGU Receives CCNE Accreditation for 10 Years
-
HF Fund: Auction in connection with the sale of bonds in series LSS150434
-
ALK launches new growth strategy and 2028 financial ambitions
-
Digital Holdings Group Champions Renewable Energy in Bitcoin Mining Sector
-
OKX Launches Industry's First 'Hybrid Spreads' Orderbooks for Cross-Currency Arbitrage Trading, Tailored for Market-Neutral Funds
-
Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly
-
Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Sy
-
Digital Holdings Group Champions Renewable Energy in Bitcoin Mining Sector
-
OKX Launches Industry's First 'Hybrid Spreads' Orderbooks for Cross-Currency Arbitrage Trading, Tailored for Market-Neutral Funds
-
HeartFlow AI Plaque Analysis Achieves Major Milestone Towards Medicare Coverage
-
VGP NV: Voting Rights and Denominator
-
Kadant Acquires Dynamic Sealing Technologies
-
Sustainable Green Team, Ltd. (SGTM) Signs Purchase Agreement to Acquire Patents and Intellectual Property for Disruptive Agricultural Technologies
-
CenTrak Announces Partnership with The Leapfrog Group
-
Bouygues : Monthly disclosure of the total number of shares and voting rights
-
Societe Generale: Information regarding executed transactions within the framework of a share buyback program (outside the liquidity agreement)
-
RUBIS: Information relating to the total number of voting rights and shares as of 31/05/2024
-
Monthly information on the total number of shares and voting rights at May 31 2024
-
Bouygues: Disclosure of trading in own shares
-
TOUAX : Disclosure of Share Capital and Voting Rights
-
ASM share buyback update May 27 – 31, 2024
-
COFACE SA: Disclosure of total number of voting rights and number of shares in the capital as at 31 May 2024
-
Nexity: Monthly disclosure of the total number of voting rights and shares composing the share capital as of 31 May 2024
-
Announcement of the total number of voting rights as at 31 May 2024
-
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases